Ratings Krishna Institute of Medical Sciences Limited Bombay S.E.

Equities

KIMS

INE967H01017

Market Closed - Bombay S.E. 06:00:52 2024-06-28 am EDT 5-day change 1st Jan Change
2,084 INR -0.92% Intraday chart for Krishna Institute of Medical Sciences Limited +1.42% +5.35%

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • The company has a poor ESG score according to Refinitiv, which ranks companies by sector.

Strengths

  • Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 62% by 2026.
  • The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
  • Analysts covering this company mostly recommend stock overweighting or purchase.

Weaknesses

  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 50.02 times its estimated earnings per share for the ongoing year.
  • The company's "enterprise value to sales" ratio is among the highest in the world.
  • In relation to the value of its tangible assets, the company's valuation appears relatively high.
  • The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Healthcare Facilities & Services

1st Jan change Capi. Investor Rating ESG Refinitiv
+5.35% 2B
C-
+18.69% 84.15B
C+
-25.20% 74.14B
B-
+1.62% 26.92B
C+
-10.46% 17.15B
B
-0.68% 16.83B
A-
-0.73% 15.21B
A-
+72.88% 13.3B
C-
+76.04% 12.99B
C+
-25.79% 12.79B - -
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. KIMS Stock
  4. KIMS Stock
  5. Ratings Krishna Institute of Medical Sciences Limited